Lexaria Bioscience Corp (LEXX)

[Gaffer222]

Lexaria Institutional Holdings Update

Hello Lexaria Community,

Just a quick note directed mostly to our shareholders. We’ve had some pleasant developments unfolding lately that we wanted to ensure you were aware of.

Simply stated, our exposure to institutional analysts and investors is increasing. Notwithstanding the challenging market environment, our progress with human clinical trials and other applied R&D seems to be paying off with those people who are particularly familiar with the biotech industry.

Why do we say that? Because the fraction of our company owned by institutions is increasing. According to the latest data recently published at Nasdaq our institutional ownership is now 11.6% which is the highest it has been during 2022. As a reminder, we only have 5.95 million shares issued and outstanding, which is a very low number within our peer group of companies.

The table below shows our ten largest institutional shareholders according to their latest regulatory filings. Collectively, all our institutional shareholders own 690,344 shares according to their disclosures.

OWNER NAME SHARES HELD VALUE $ (IN 1,000S)
Invenomic Capital Management LP 473,103 1,017
Geode Capital Management, LLC 49,002 105
Susquehanna International Group, LLP 40,119 86
Vanguard Group Inc 33,164 71
Citadel Advisors LLC 24,874 53
Dimensional Fund Advisors LP 15,264 33
Centiva Capital, LP 13,259 29
Two Sigma Investments, LP 13,063 28
Renaissance Technologies LLC 11,900 26
UBS Group AG 6,398 14
In addition, I personally purchased an additional 38,500 shares of our common stock in October, in the open market, to hold a little more than 520,000 shares in total: I remain the largest shareholder of Lexaria and my conviction in the long-term prospects of this company is stronger than ever.

I’ve also been delighted to see a number of private shareholders greatly adding to their positions during recent weeks: you know who you are and we appreciate your support!

Thanksgiving is around the corner for all our US stakeholders: we wish you a safe and joyous holiday and prosperity to come!

Chris Bunka
CEO, Lexaria Bioscience Corp.